• Something wrong with this record ?

Posterior corneal vesicles are not associated with the genetic variants that cause posterior polymorphous corneal dystrophy

P. Liskova, NJ. Hafford-Tear, P. Skalicka, F. Malinka, J. Jedlickova, Ľ. Ďuďáková, N. Pontikos, AE. Davidson, S. Tuft

. 2022 ; 100 (7) : e1426-e1430. [pub] 20220217

Language English Country England, Great Britain

Document type Journal Article

Grant support
MR/S031820/1 Medical Research Council - United Kingdom

E-resources Online Full text

NLK Free Medical Journals from 2008 to 1 year ago
Medline Complete (EBSCOhost) from 2008-02-01 to 1 year ago
Wiley Free Content from 2008 to 1 year ago

PURPOSE: Posterior corneal vesicles (PCVs) have clinical features that are similar to posterior polymorphous corneal dystrophy (PPCD). To help determine whether there is a shared genetic basis, we screened 38 individuals with PCVs for changes in the three genes identified as causative for PPCD. METHODS: We prospectively recruited patients for this study. We examined all individuals clinically, with their first-degree relatives when available. We used a combination of Sanger and exome sequencing to screen regulatory regions of OVOL2 and GRHL2, and the entire ZEB1 coding sequence. RESULTS: The median age at examination was 37.5 years (range 4.7-84.0 years), 20 (53%) were male and in 19 (50%) the PCVs were unilateral. Most individuals were discharged to optometric review, but five had follow-up for a median of 12 years (range 5-13 years) with no evidence of progression. In cases with unilateral PCVs, there was statistically significant evidence that the change in the affected eye was associated with a lower endothelial cell density (p = 0.0003), greater central corneal thickness (p = 0.0277) and a steeper mean keratometry (p = 0.0034), but not with a higher keratometric astigmatism or a reduced LogMAR visual acuity. First-degree relatives of 13 individuals were available for examination, and in 3 (23%), PCVs were identified. No possibly pathogenic variants were identified in the PPCD-associated genes screened. CONCLUSION: We found no evidence that PCVs share the same genetic background as PPCD. In contrast to PPCD, we confirm that PCVs is a mild, non-progressive condition with no requirement for long-term review. However, subsequent cataract surgery can lead to corneal oedema.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22032940
003      
CZ-PrNML
005      
20230131151430.0
007      
ta
008      
230120s2022 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/aos.15114 $2 doi
035    __
$a (PubMed)35174971
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Liskova, Petra $u Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $u Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $1 https://orcid.org/0000000178348486
245    10
$a Posterior corneal vesicles are not associated with the genetic variants that cause posterior polymorphous corneal dystrophy / $c P. Liskova, NJ. Hafford-Tear, P. Skalicka, F. Malinka, J. Jedlickova, Ľ. Ďuďáková, N. Pontikos, AE. Davidson, S. Tuft
520    9_
$a PURPOSE: Posterior corneal vesicles (PCVs) have clinical features that are similar to posterior polymorphous corneal dystrophy (PPCD). To help determine whether there is a shared genetic basis, we screened 38 individuals with PCVs for changes in the three genes identified as causative for PPCD. METHODS: We prospectively recruited patients for this study. We examined all individuals clinically, with their first-degree relatives when available. We used a combination of Sanger and exome sequencing to screen regulatory regions of OVOL2 and GRHL2, and the entire ZEB1 coding sequence. RESULTS: The median age at examination was 37.5 years (range 4.7-84.0 years), 20 (53%) were male and in 19 (50%) the PCVs were unilateral. Most individuals were discharged to optometric review, but five had follow-up for a median of 12 years (range 5-13 years) with no evidence of progression. In cases with unilateral PCVs, there was statistically significant evidence that the change in the affected eye was associated with a lower endothelial cell density (p = 0.0003), greater central corneal thickness (p = 0.0277) and a steeper mean keratometry (p = 0.0034), but not with a higher keratometric astigmatism or a reduced LogMAR visual acuity. First-degree relatives of 13 individuals were available for examination, and in 3 (23%), PCVs were identified. No possibly pathogenic variants were identified in the PPCD-associated genes screened. CONCLUSION: We found no evidence that PCVs share the same genetic background as PPCD. In contrast to PPCD, we confirm that PCVs is a mild, non-progressive condition with no requirement for long-term review. However, subsequent cataract surgery can lead to corneal oedema.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    12
$a astigmatismus $7 D001251
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a rohovka $x patologie $7 D003315
650    12
$a dědičné dystrofie rohovky $x diagnóza $x genetika $7 D003317
650    12
$a edém rohovky $7 D015715
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a transkripční faktory $x genetika $7 D014157
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hafford-Tear, Nathaniel J $u UCL Institute of Ophthalmology, London, UK
700    1_
$a Skalicka, Pavlina $u Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Malinka, Frantisek $u Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $u Department of Computer Science, Czech Technical University in Prague, Prague, Czech Republic
700    1_
$a Jedlickova, Jana $u Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Ďuďáková, Ľubica $u Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Pontikos, Nikolas $u UCL Institute of Ophthalmology, London, UK
700    1_
$a Davidson, Alice E $u UCL Institute of Ophthalmology, London, UK
700    1_
$a Tuft, Stephen $u UCL Institute of Ophthalmology, London, UK $u Moorfields Eye Hospital, London, UK $1 https://orcid.org/0000000181925192
773    0_
$w MED00179743 $t Acta ophthalmologica $x 1755-3768 $g Roč. 100, č. 7 (2022), s. e1426-e1430
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35174971 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230120 $b ABA008
991    __
$a 20230131151426 $b ABA008
999    __
$a ok $b bmc $g 1891606 $s 1184275
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2022 $b 100 $c 7 $d e1426-e1430 $e 20220217 $i 1755-3768 $m Acta ophthalmologica $n Acta Ophthalmol $x MED00179743
GRA    __
$a MR/S031820/1 $p Medical Research Council $2 United Kingdom
LZP    __
$a Pubmed-20230120

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...